Thursday, October 8, 2020

Does Pharmaceutical Compounding of Vascular Endothelial Growth Factor Inhibitors for Intravitreal Use Alter the Risk of Post-injection Endophthalmitis? Kathrine Blom , MDORCID Icon,Ragnheiður Bragadóttir , MD, PhD,Magne Sand Sivertsen , MD, PhD,Morten Carstens Moe , MD, PhD &Ystein Kalsnes Jørstad , MD, PhDORCID Icon Received 29 Apr 2020, Accepted 03 Sep 2020, Published online: 07 Oct 2020

https://www.tandfonline.com/doi/abs/10.1080/09273948.2020.1820530?journalCode=ioii20 

No comments: